Bbr Partners, LLC Biogen Inc. Transaction History

Bbr Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $2,131 - $2,685	11 Added 0.85%	1,298 $273,000
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $1,295 - $2,073	-5 Reduced 0.39%	1,287 $446,000
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $485 - $569	2 Added 0.16%	1,292 $361,000
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $708 - $1,066	3 Added 0.23%	1,290 $316,000
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $340,758 - $393,448	1,287 New	1,287 $365,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Bbr Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Bbr Partners, LLC with notifications on news.